IQVIA Rakes in Industry Awards for AI-Driven Healthcare and Life Sciences Solutions — IQVIA Holdings Inc.

Event summary

IQVIA won five industry awards in 2026 for its AI-driven solutions in healthcare and life sciences.
The IQVIA Literature AI Platform achieved 100% recall in search and reduced screening workload by over 90%.
IQVIA’s Privacy Analytics Platform enabled 110,000 additional procedures and reduced discharge delays by 14.9% in the NHS Federated Data Platform.
The IQVIA Interactive Response Technology (IRT) SAVE program cut clinical trial drug supply shortages by 76% and deliveries by 73%.
IQVIA’s AI-enabled clinical decision support tool reduced type 1 diabetes screening burden by 99.5% and improved patient identification by 127x.

The big picture

IQVIA’s award wins highlight the growing demand for AI-driven solutions in healthcare and life sciences, particularly in areas like clinical trial optimization, regulatory compliance, and patient privacy. The company’s ability to deliver measurable outcomes—such as reducing clinical trial drug shortages and accelerating regulatory approvals—positions it as a key player in an industry under pressure to innovate faster. With a global footprint and a focus on responsible AI, IQVIA is well-positioned to capitalize on the trend toward data-driven decision-making in healthcare.

What we're watching

AI Adoption: How IQVIA’s AI-driven solutions will affect the pace of adoption across the life sciences industry.
Regulatory Efficiency: Whether IQVIA’s AI-enabled Regulatory Information Management platform can sustain its impact on global regulatory approvals.
Clinical Trial Optimization: The pace at which IQVIA’s IRT SAVE program will expand to other clinical trial operations.